Wellnex Life Ltd (ASX: WNX) Share Price and News
Price
–
Movement
– ( )
(20 mins delayed)
52 Week Range
– - –
1 Year Return
Wellnex Life Ltd Chart and Price Data
Fundamentals Data provided by Morningstar.
Data provided by Morningstar.
Market Cap
$22.82 million
P/E Ratio
N/A
Dividend Yield
0.00%
Shares Outstanding
67.13 million
Earnings per share
-0.164
Dividend per share
N/A
Year To Date Return
-43.16%
Earnings Yield
N/A
Franking
-
Share Price
–
Day Change
– ( )
52 Week Range
– - –
Yesterday's Close
–
Today's Open
–
Days Range
– - –
Volume
–
Avg. Volume (1 month)
–
Turnover
–
Wellnex Life Ltd (ASX: WNX)
Latest News
Share Market News
Here's why the Wellnex Life (ASX:WNX) share price jumped 37% today
Share Fallers
Why the Wellnex Life (ASX:WNX) share price is crashing 75% lower on Thursday
Capital Raising
ASX infant formula group Wattle Health to raise $39.7 million in new shares
Growth Investing
Can ASX infant formula shares soar in 2020?
Share Market News
Infant formula company Wattle Health to remain suspended after failed rights issue
Share Market News
Wattle Health announces deal with Chemist Warehouse
Share Market News
Wattle Health announces new China-based joint venture
Share Fallers
Why Clinuvel, Newcrest, Starpharma, & Wattle Health shares dropped lower
Share Fallers
Why Beach, Pro Medicus, South32, & Wattle Health tumbled lower today
Share Market News
Why ARQ, Fortescue, iSignthis, & Wattle Health shares are sinking lower
Share Gainers
The Wattle Health share price is up 95% in a week
Share Gainers
Why Clover, IOOF, Premier Investments, & Wattle Health surged higher today
WNX ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|
About Wellnex Life Ltd
Wellnex Life Ltd. engages in the provision of health and wellness products. It specializes on production of dairy products focuses on infant formula and dried dairy goods. The company was founded by Lazarus Karasavvidis and Martin Glenister on May 6, 2011 and is headquartered in Port Melbourne, Australia.
WNX Share Price History Data provided by Morningstar.
| Date | Close | Change | % Change | Volume | Open | High | Low |
|---|---|---|---|---|---|---|---|
| 24 Apr 2025 | $0.34 | $-0.03 | -8.22% | 21,915 | $0.35 | $0.35 | $0.33 |
| 23 Apr 2025 | $0.37 | $0.06 | 19.35% | 102,608 | $0.31 | $0.37 | $0.31 |
| 22 Apr 2025 | $0.31 | $0.02 | 6.90% | 31,850 | $0.31 | $0.31 | $0.30 |
| 17 Apr 2025 | $0.29 | $-0.05 | -14.71% | 106,171 | $0.30 | $0.30 | $0.29 |
| 16 Apr 2025 | $0.34 | $0.02 | 6.15% | 53,597 | $0.33 | $0.34 | $0.30 |
| 15 Apr 2025 | $0.33 | $-0.01 | -3.03% | 57,822 | $0.32 | $0.33 | $0.31 |
| 14 Apr 2025 | $0.33 | $-0.01 | -2.94% | 40,349 | $0.33 | $0.35 | $0.33 |
| 11 Apr 2025 | $0.34 | $0.00 | 0.00% | 28,326 | $0.35 | $0.35 | $0.33 |
| 10 Apr 2025 | $0.35 | $0.05 | 16.95% | 127,967 | $0.34 | $0.35 | $0.32 |
| 09 Apr 2025 | $0.30 | $-0.01 | -3.33% | 129,399 | $0.34 | $0.35 | $0.29 |
| 08 Apr 2025 | $0.30 | $0.04 | 15.38% | 195,365 | $0.27 | $0.31 | $0.27 |
| 07 Apr 2025 | $0.26 | $-0.09 | -25.71% | 335,081 | $0.34 | $0.34 | $0.26 |
| 04 Apr 2025 | $0.35 | $-0.01 | -2.78% | 52,585 | $0.35 | $0.35 | $0.33 |
| 03 Apr 2025 | $0.36 | $-0.05 | -12.20% | 85,914 | $0.41 | $0.41 | $0.35 |
| 02 Apr 2025 | $0.41 | $0.00 | 0.00% | 109,591 | $0.35 | $0.41 | $0.35 |
| 01 Apr 2025 | $0.41 | $-0.05 | -10.87% | 461,105 | $0.42 | $0.42 | $0.32 |
| 31 Mar 2025 | $0.46 | $-0.02 | -4.21% | 50,982 | $0.46 | $0.46 | $0.42 |
| 28 Mar 2025 | $0.48 | $-0.01 | -2.06% | 91,777 | $0.49 | $0.49 | $0.44 |
| 27 Mar 2025 | $0.49 | $0.02 | 4.30% | 21,940 | $0.57 | $0.57 | $0.43 |
Director Transactions Data provided by Morningstar.
| Date | Director | Type | Amount | Value | Notes |
|---|---|---|---|---|---|
| 05 Mar 2025 | George Karafotias | Issued | 68,064 | $44,242 |
Rights issue.
|
| 05 Mar 2025 | Zlatko (Zack) Bozinovski | Issued | 184,615 | $120,000 |
Rights issue.
|
| 05 Mar 2025 | Jeffrey Yeh | Issued | 1,999,999 | $1,300,000 |
Rights issue.
|
| 07 Feb 2025 | Jeffrey Yeh | Issued | 871,429 | $697,143 |
Issue of securities. Deemed Issue
|
| 23 Dec 2024 | Jeffrey Yeh | Issued | 200,000 | $280,000 |
Issue of securities. No cash consideration
Deemed Issue |
| 17 Oct 2024 | George Karafotias | Buy | 5,000 | $4,420 |
On-market trade. .
|
| 16 Sep 2024 | Zlatko (Zack) Bozinovski | Buy | 1,190,593 | $25,002 |
On-market trade.
|
Directors & Management Data provided by Morningstar.
| Name | Title | Start Date | Profile |
|---|---|---|---|
| Mr Eric Jiang | Non-Executive Director | Sep 2016 |
Mr Jiang has over 15 years' experience and is an adviser to companies involved in trade between Australia and China. Eric brings understanding of the cultural, economic and strategic context in which Australian businesses engage with China.
|
| Mr George Karafotias | Chief Financial OfficerExecutive Director | Nov 2020 |
Mr Karafotias has held roles in public companies over the last 9 years and has previously provided corporate advisory services to listed and unlisted companies, focusing on restructuring and refinancing.
|
| Mr George Tambassis | Non-Executive Director | Sep 2024 |
--
|
| Mr Zlatko (Zack) Bozinovski | Chief Strategy OfficerExecutive Director | Jul 2021 |
Mr Bozinovski is executive in the Australian retail industry with over 35 years' experience within FMCG and Pharmaceuticals companies in Australia and internationally. Mr Bozinovski co-founded Voost and has previously held senior positions at Uncle Tobys/Goodman Fielder, Pepsi Co and Sigma Pharmaceuticals.
|
| Mr Andrew Vidler | Non-Executive Director | Jan 2024 |
Mr Vidler has experience across retail, consumer health products and retail pharmacy. Andrew in his over 30 years' experience includes nearly 20 years with the EBOS Group (formerly FH Faulding, Mayne Group and Symbion), where across roles he led the Terry White and Chemmart pharmacy brands and the Endeavour consumer health products business.
|
| Mr Jeffrey Yeh | Non-Executive Director | Jan 2024 |
Mr Yeh is an experienced all-rounded entrepreneur, with over 21 years' experience in all aspects of pharmaceutical sales, marketing, production, quality assurance, operations, logistics, finance and management.
|
| Mr Ruari McGirr | Non-Executive Director | Mar 2025 |
--
|
| Mr Yuan (Vivenne) Zhang | Non-Executive Director | Mar 2025 |
--
|
| Mr Zheng (Kobe) Li | Company Secretary | Jan 2019 |
-
|
| Zheng (Kobe) Li | Company Secretary |
-
|
Top Shareholders Data provided by Morningstar.
| Name | Shares | Capital |
|---|---|---|
| Homart Group Pty Ltd | 83,508,573 | 5.96% |
| Kobella Holdings Pty Ltd (The Kobella Holding Unit A/C) | 68,571,428 | 4.89% |
| Jysf Management Pty Ltd (Jysf A/C) | 65,729,522 | 4.69% |
| Kirby Superannuation Pty Ltd (Kirby Super Fund A/C) | 40,154,760 | 2.86% |
| Ggp Investments Pty Ltd (Ggp Superannuation Fund A/C) | 32,732,760 | 2.33% |
| Citicorp Nominees Pty Limited | 32,661,975 | 2.33% |
| Gleneagle Securities Nominees Pty Limited | 32,142,855 | 2.29% |
| HSBC Custody Nominees (Australia) Limited | 30,559,496 | 2.18% |
| Morrison Securities Pty Ltd (Placements A/C) | 28,836,995 | 2.06% |
| Zjl Pty Ltd (The Bozinovski Family A/C) | 24,142,857 | 1.72% |
| 18120 Pty Ltd (Hmej A/C) | 22,657,143 | 1.62% |
| Lotus Capital Group Pty Ltd | 19,882,100 | 1.42% |
| Gleneagle Securities (Aust) Pty Ltd | 19,700,000 | 1.41% |
| Pear Management Pty Ltd | 19,603,863 | 1.40% |
| Reid Jon Zulpo (Rj & Mc Zulpo Family A/C) | 19,021,740 | 1.36% |
| Cw Retail Holdings Pty Ltd (Cw Retail Holdings A/C) | 18,869,792 | 1.35% |
| Wattle Trading Pty Ltd | 18,831,453 | 1.34% |
| Onslow Management Services Pty Ltd Ltd (Esperance A/C) | 17,857,143 | 1.27% |
| Monex Boom Securities (Hk) Ltd (Clients Account) | 17,750,302 | 1.27% |
| Mrs Jieni Jeffrey | 16,669,265 | 1.19% |